ARCHIVES

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

Top Officials Resign From San Antonio’s Institute for Drug Development.

January 26, 2007

Toxicology Program Seeks Comment On Substances.

March 23, 2001

NCS Heeds Bloch’s Plea, To Consider Establishing Separate PDQ-Like System For General Public Use

December 7, 1984

NCI Reorganization: DEC Epidemiology Stays In Place, DCPC To Build Its Own – No Decision Yet Enters, Other DCPC Program – CIS Moved To OCC, ICIC ut Of OIA

June 24, 1988

Letter: The Lesson From Dana-Farber

July 28, 1995

Bioassay Program To NIEHS” NCI Denies Rumor

March 31, 1978